- Previous Close
23.80 - Open
23.50 - Bid 23.55 x 3600
- Ask 23.70 x 6200
- Day's Range
23.05 - 23.95 - 52 Week Range
23.05 - 48.60 - Volume
5,963 - Avg. Volume
22,634 - Market Cap (intraday)
286.271M - Beta (5Y Monthly) 0.54
- PE Ratio (TTM)
28.72 - EPS (TTM)
0.82 - Earnings Date Apr 29, 2025
- Forward Dividend & Yield 0.55 (2.31%)
- Ex-Dividend Date May 20, 2024
- 1y Target Est
41.00
Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.
www.stratec.comRecent News: SBS.DE
View MorePerformance Overview: SBS.DE
Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is DAX P (^GDAXI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SBS.DE
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SBS.DE
View MoreValuation Measures
Market Cap
289.31M
Enterprise Value
396.47M
Trailing P/E
29.02
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.15
Price/Book (mrq)
1.27
Enterprise Value/Revenue
1.58
Enterprise Value/EBITDA
10.39
Financial Highlights
Profitability and Income Statement
Profit Margin
4.00%
Return on Assets (ttm)
3.13%
Return on Equity (ttm)
4.41%
Revenue (ttm)
250.54M
Net Income Avi to Common (ttm)
10.01M
Diluted EPS (ttm)
0.82
Balance Sheet and Cash Flow
Total Cash (mrq)
33.11M
Total Debt/Equity (mrq)
66.97%
Levered Free Cash Flow (ttm)
-48.1M